LV Mass Index (LVMI) Calculator

Clinical calculation support · Verify results before clinical use

Patient Data

Enter end-diastolic linear measurements and body surface area to estimate LV mass and geometry.

4Inputs
Patient sex
Sex-specific upper reference limits are used for LV mass index.
Measure using a standardized echocardiographic technique at end-diastole.
Enter BSA calculated from the patient's height and weight.

About LV Mass Index

Left ventricular mass index (LVMI) is left ventricular mass indexed to body surface area. It is used to assess increased LV mass and characterize patterns of ventricular remodeling.

This calculator uses the Devereux-modified ASE cube formula from end-diastolic linear echocardiographic measurements. The method assumes a relatively regular LV shape and should be interpreted in that context.

Calculation

Left ventricular mass:
LV mass = 0.8 × 1.04 × [(IVSd + LVIDd + PWTd)3 − LVIDd3] + 0.6 g

Left ventricular mass index:
LVMI = LV mass / BSA

Relative wall thickness:
RWT = (2 × PWTd) / LVIDd

Reference Limits and LV Geometry

For the ASE/EACVI linear measurement method, the upper reference limits for LV mass indexed to BSA are 115 g/m2 for men and 95 g/m2 for women. An RWT threshold of 0.42 is used to characterize LV geometry.

LV mass indexRWTLV geometry
Normal≤ 0.42Normal geometry
Normal> 0.42Concentric remodeling
Increased> 0.42Concentric hypertrophy
Increased≤ 0.42Eccentric hypertrophy

Clinical Interpretation

Increased LV mass may occur with chronic pressure or volume overload and is often encountered in conditions such as hypertension and aortic valve disease.

Concentric remodeling describes normal LV mass with increased RWT. Concentric hypertrophy describes increased LV mass with increased RWT, while eccentric hypertrophy describes increased LV mass with RWT at or below 0.42.

LVMI should be interpreted with LV dimensions, wall thickness, systolic and diastolic function, valvular findings, and the patient's clinical condition.

Important Limitations

  • The linear/cube method assumes a relatively regular LV geometry and may be less reliable with substantial geometric abnormalities.
  • Use caution with asymmetric hypertrophy, marked LV dilatation, aneurysm, or regional abnormalities not adequately represented by linear measurements.
  • Because dimensions are cubed, small measurement differences can produce meaningful changes in estimated LV mass.
  • Use standardized end-diastolic measurements and consistent methods when comparing serial examinations.
  • When LV geometry is abnormal or precise quantification is important, consider 2D/3D echocardiography or cardiac magnetic resonance according to clinical context.

References

  1. Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1–39. doi:10.1016/j.echo.2014.10.003.
  2. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57(6):450–458. doi:10.1016/0002-9149(86)90771-X.
  3. Marwick TH, Gillebert TC, Aurigemma G, et al. Recommendations on the Use of Echocardiography in Adult Hypertension. J Am Soc Echocardiogr. 2015;28(7):727–754. doi:10.1016/j.echo.2015.05.002.